<< Back
Feb 28, 2017

Chimerix to Present at Cowen and Company 37th Annual Health Care Conference

DURHAM, N.C., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company committed to discovering, developing and   commercializing medicines that address significant, unmet medical needs, today announced that Garrett Nichols, M.D., M.S., Chief Medical Officer of Chimerix, will present a corporate overview at the Cowen and Company 37th Annual Health Care Conference on Tuesday, March 7, 2017 at 8:00 a.m. ET at the Boston Marriott Copley Place.

A live audio webcast of the presentation will be available on the Investor Relations section of Chimerix's website at, where it will be archived for approximately 90 days.                                                   

About Chimerix

Chimerix is a biopharmaceutical company committed to discovering, developing and commercializing medicines that address significant unmet medical needs.  Chimerix's proprietary lipid conjugate technology has produced brincidofovir (BCV); CMX157, which was licensed to ContraVir Pharmaceuticals; and earlier-stage clinical candidates. Chimerix recently announced a new clinical candidate, CMX521, for the treatment and/or prevention of norovirus. For further information, please visit Chimerix's website, 


Investor Relations:


Will O'Connor

Stern Investor Relations



Becky Vonsiatsky



Primary Logo

Source: Chimerix, Inc.

News Provided by Acquire Media